A Trial of SHR-7782 for Treatment of Advanced Malignant Tumors

NCT07123129 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignancy

Interventions

DRUG: SHR-7782 Injection

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.